DeepRad.AI’s AI Multimodal Imaging Health Platform, DeepLung-CAC, garnered widespread attention at this year’s Asia Bay Innovation Expo with its groundbreaking technology, making a remarkable impact.

By integrating multimodal AI technology with low-dose lung CT scan imaging, DeepLung-CAC can detect and locate lung nodules while also assessing coronary artery calcification levels. Addressing two major health threats—lung cancer and heart disease—DeepLung-CAC provides an early detection solution and a crucial window for timely medical intervention. Additionally, it automatically generates reports that comply with Health Promotion Administration standards, significantly enhancing the efficiency of medical workflows and making screenings more effective.

DeepRad.AI’s  technology has earned multiple prestigious accolades, including the National Innovation Award (InnoAward) and the Future Tech Award (Futex), as well as recognition from Johnson & Johnson and Microsoft. Most recently, we were honored with the Google Award, further solidifying our leadership in the healthcare technology sector. Moving forward, we are actively developing AI platforms for osteoporosis and dementia prediction, continuing to drive innovation in preventive healthcare.